The Italy Vendor Neutral Archive (VNA) & PACS Market was valued at $91.9 Million in 2026 and projected to reach to $141.3 Million by 2031, representing a compound annual growth rate of 9.0%. Italy's VNA and PACS market is positioned for sustained growth as healthcare providers increasingly recognize the value of vendor-neutral, interoperable imaging solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Italy's VNA and PACS market is valued at USD 91.9 million in 2026, with strong expansion projected to USD 141.3 million by 2031, representing a robust 9.0% CAGR.
Italian healthcare institutions are actively modernizing their digital infrastructure, driving widespread adoption of interoperable medical imaging solutions across hospitals and diagnostic centers nationwide.
The shift toward vendor-neutral solutions reflects Italy's commitment to breaking down data silos, enabling seamless integration across multiple healthcare providers and improving patient care coordination.
Italy's healthcare system is prioritizing technology investments to enhance operational efficiency, reduce costs, and meet EU digital health standards, creating sustained demand for VNA and PACS solutions.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | INDIA (Modality) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 8.9% from 2026 to 2031 |
| Largest Segment | VNA (Product Type) |
| Market Size Base Year (Billions) | ~USD 5.6 (2026) |
| Revenue Forecast (Billions) | ~USD 8.57 (2031) |
| Segments Covered | Product Type, Modality, Deployment Model, Type, Vendor Type, Application, End User, Type 2023–2030 |
8 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| AGFA-GEVAERT GROUP | Belgium | Public Company | Healthcare enterprise imaging platform and software,Diagnostic imaging hardware, X-ray and hardcopy film, and DR equipment,Sign & display and packaging printers, inks, and software, |
| FUJIFILM HOLDINGS CORPORATION | Japan | Public Company | Healthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, storage, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications), |
| SECTRA AB | Sweden | Public Company | Imaging IT Solutions (enterprise imaging, PACS/VNA, services),Secure Communications,Business Innovation (orthopedics, medical education, precision diagnostics IT), |
| GE HEALTHCARE | United States | Public Company | Imaging (CT, MR, X-ray, Molecular, Women’s Health),Advanced Visualization Solutions & Ultrasound / Image-Guided Therapies,Patient Care Solutions (Monitoring, Cardiology, Maternal Infant, Anesthesia, Digital), |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health, |
| HYLAND SOFTWARE, INC. | United States | Private Company | OnBase platform (ECM, workflow, case management),Healthcare imaging and interoperability (Hyland Healthcare, Acuo, NilRead, PACSgear, Mackinac),Legacy ECM/BPM suites (Perceptive Content, Perceptive Process, Saperion, NolijWeb), |
| ASPYRA, LLC | United States | Public Company | Laboratory information and workflow solutions,Imaging and orthopedic workflow solutions,Hardware, integration, and professional services, |
Agfa-Gevaert Group is a Belgian public company established in 1867 with 4,211 employees, operating across imaging and healthcare technology sectors.
Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, engaged in imaging, healthcare, and materials technology.
Sectra AB is a Swedish public company established in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.
GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees, providing medical imaging and healthcare technology solutions.
Koninklijke Philips N.V. is a Dutch multinational public company established in 1891 with 64,317 employees, operating in healthcare, lighting, and consumer electronics.
Hyland Software, Inc. is a United States private company established in 1991 with 336 employees, developing content management and workflow automation solutions.
Aspyra, LLC is a United States public company founded in 1978 with 70 employees, specializing in healthcare imaging and information management systems.
Italy's VNA & PACS market was valued at USD 91.9 million in 2026 and is projected to reach USD 141.3 million by 2031.
Italy's VNA & PACS market is expected to grow at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2031.
Italy's mid-sized and regional hospitals, along with diagnostic imaging centers, are the primary drivers of VNA & PACS adoption seeking interoperable and cost-effective solutions.
Italy's alignment with EU interoperability standards, healthcare digitalization mandates, and data exchange requirements create a favorable regulatory environment for VNA & PACS deployment.
Italy's 9.0% CAGR slightly exceeds the global average of 8.9%, reflecting strong regional demand for vendor-neutral imaging solutions and healthcare IT modernization.
The study involved five major activities to estimate the current size of the VNA & PACS market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of the VNA PACS market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Extensive primary research was conducted after acquiring basic knowledge about the VNA & PACS market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARIES

Note 2: Tiers of companies are defined based on their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the VNA & PACS market. These methods were also used extensively to estimate the size of various subsegments in the market.

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and determine the exact statistics for each market segment and sub-segment, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the VNA & PACS market.
VNA and PACS are medical imaging technologies that offer cost-effective storage and easy access to images from various modalities. These solutions are essential elements of modern healthcare IT infrastructure, enabling the efficient and secure digitization, storage, retrieval, and sharing of medical imaging data.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Vendor Neutral Archive (VNA) & PACS Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report